other material
confidence high
sentiment neutral
materiality 0.45
Avenue Therapeutics stockholders approve 5M share increase to 2015 Incentive Plan
AVENUE THERAPEUTICS, INC.
- Stockholders approved amendment to 2015 Incentive Plan, increasing authorized shares by 5,000,000.
- Plan term extended to June 24, 2034; non-employee director annual limit increased to 500,000 shares.
- All six director nominees elected; KPMG ratified as auditor for FY2024.
- Total shares reserved under the plan after amendment: 5,070,223.